IDYA
IDEAYA Biosciences Inc.
$25.73
-$0.19(-0.73%)
66
Overall
--
Value
66
Tech
--
Quality
Market Cap
$2.26B
Volume
640.83K
52W Range
$13.45 - $36.64
Target Price
$46.94
Order:
Income Statement
| Metric | Trend | Chart | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Total Revenue | -- | $19.5M | $27.9M | $50.9M | $23.4M | $7.0M | ||
| Total Revenue | -- | $19.5M | $27.9M | $50.9M | $23.4M | $7.0M | ||
| GROSS PROFIT | ||||||||
| Gross Profit | -- | $19.5M | $27.9M | $50.9M | $23.4M | $7.0M | ||
| OPERATING EXPENSES | ||||||||
| Operating Expenses | $44.3M | $54.9M | $78.2M | $113.4M | $157.8M | $334.0M | ||
| Research & Development | $34.3M | $39.7M | $58.2M | $89.5M | $129.5M | $294.7M | ||
| Research Expense | $34.3M | $39.7M | $58.2M | $89.5M | $129.5M | $294.7M | ||
| Selling, General & Administrative | $10.0M | $15.2M | $20.1M | $23.9M | $28.3M | $39.3M | ||
| General & Administrative Expenses | $10.0M | $15.2M | $20.1M | $23.9M | $28.3M | $39.3M | ||
| Salaries & Wages | -- | -- | -- | -- | $18.5M | $34.7M | ||
| Depreciation & Amortization | $1.2M | $1.4M | $1.7M | $2.1M | $2.5M | $2.4M | ||
| Depreciation & Amortization | $1.2M | $1.4M | $1.7M | $2.1M | $2.5M | $2.4M | ||
| Other Operating Expenses | $-288.0K | $-153.0K | $-330.0K | $-607.0K | $-1.5M | $-2.3M | ||
| OPERATING INCOME | ||||||||
| Operating income | $-44.3M | $-35.3M | $-50.3M | $-62.5M | $-134.4M | $-327.0M | ||
| EBITDA | $-41.2M | $-34.0M | $-47.2M | $-59.0M | $-109.0M | $-270.6M | ||
| NON-OPERATING ITEMS | ||||||||
| Intinc | $2.3M | -- | -- | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $2.3M | -- | -- | $-3.8M | $-21.5M | -- | ||
| Other Income/Expense | $-2.3M | $-849.0K | $-506.0K | $-3.8M | $-21.5M | $-52.5M | ||
| Other Special Charges | $2.3M | $849.0K | $506.0K | $3.8M | $21.5M | $52.5M | ||
| PRE-TAX INCOME | ||||||||
| EBIT | $-42.0M | $-35.3M | $-50.3M | $-62.5M | $-113.0M | $-274.5M | ||
| Pre-Tax Income | $-42.0M | $-34.5M | $-49.8M | $-58.7M | $-113.0M | $-274.5M | ||
| NET INCOME | ||||||||
| Net Income | $-42.0M | $-34.5M | $-49.8M | $-58.7M | $-113.0M | $-274.5M | ||
| Net Income (Continuing Operations) | $-42.0M | $-34.5M | $-49.8M | $-58.7M | $-113.0M | $-274.5M | ||
| Net Income (Discontinued Operations) | $-42.0M | $-34.5M | $-49.8M | $-58.7M | $-113.0M | $-274.5M | ||
| Net Income (Common Stockholders) | $-42.0M | $-34.5M | $-49.8M | $-58.7M | $-113.0M | $-274.5M | ||
| Normalized Income | -- | -- | -- | -- | $-89.2M | $-271.7M | ||
| TOTALS | ||||||||
| Total Expenses | $44.3M | $54.9M | $78.2M | $113.4M | $157.8M | $334.0M | ||
| SHARE & EPS DATA | ||||||||
| Average Shares Outstanding | $12.5M | $24.7M | $35.3M | $41.4M | $57.5M | $81.7M | ||
| Average Shares Outstanding (Diluted) | $12.5M | $24.7M | -- | $41.4M | $57.5M | $81.7M | ||
| Shares Outstanding | $20.3M | $32.3M | $38.6M | $48.4M | $74.6M | $87.5M | ||
| Basic EPS | $-3.36 | $-1.4 | $-1.41 | $-1.42 | $-1.96 | $-3.36 | ||
| Basic EPS (Continuing Operations) | $-3.36 | $-1.4 | $-1.41 | $-1.42 | $-1.96 | $-3.36 | ||
| Diluted EPS | $-3.36 | $-1.4 | $-1.41 | $-1.42 | $-1.96 | $-3.36 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | $-1.42 | $-1.96 | $-3.36 | ||
| OTHER METRICS | ||||||||
| Other Gand A | $10.0M | $15.2M | $20.1M | $23.9M | $28.3M | $39.3M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IDYA | $25.73 | -0.7% | 640.83K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |